Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UNC93B6 refers to an uncharacterized or misidentified gene/pseudogene and does not correspond to a known therapeutic target. The primary UNC93 family member of biological and therapeutic significance in humans is "Unc-93 homolog B1 (UNC93B1)", which is a multi-pass membrane protein critical for trafficking nucleic-acid–sensing Toll-like receptors (TLR3, TLR7, TLR8, TLR9) from the endoplasmic reticulum to endolysosomes, and plays a role in innate immune signaling, infection susceptibility, and autoimmunity[1][5][3]. However, UNC93B6 is annotated as a pseudogene and does not encode a functional protein, nor is it a receptor, enzyme, transporter, or an established therapeutic target[1]. UNC93B6 is likely a **pseudogene** and not a therapeutically relevant molecule. The functional molecule in this family is **UNC93B1**. No drugs, mechanisms of action, or known disease roles are associated with UNC93B6[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UNC93B6.